Immunocapture Enzyme-Linked Immunosorbent Assay for Assessment of In Vitro Potency of Recombinant Hepatitis B Vaccines

Quantification of hepatitis B surface antigen (HBsAg) or relative in vitro potency in the final vaccines is a prerequisite for hepatitis B vaccine batch release. The commercial kit for automated analysis (AxSYM) is expensive, and an alternative is required for the estimation of HBsAg in hepatitis B...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Shanmugham, Rajalakshmi, Thirumeni, Nagarajan, Rao, Varaprasada Sankarashetty, Pitta, Vidyasagar, Kasthuri, Saranyarevathy, Singanallur, Nagendrakumar Balasubramanian, Lingala, Rajendra, Mangamoori, Lakshmi Narsu, Villuppanoor, Srinivasan Alwar
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology (ASM) 2010
Sujets:
Clinical Laboratory Immunology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2916243/
https://ncbi.nlm.nih.gov/pubmed/20592114
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00192-10
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires